References of "Neurone"
Bookmark and Share    
Full Text
Laloyaux, Julien ULg; Levaux, Marie-Noëlle ULg; Domken, Marc-André et al

in Neurone (2015), 20(7),

Detailed reference viewed: 36 (5 ULg)
Full Text
See detailAnalyse de l'efficacité des programmes d'éducation rachidienne pour la prévention des lombalgies
Demoulin, Christophe ULg; Marty, M.; Genevay, S. et al

in Neurone (2013), 18

Detailed reference viewed: 52 (6 ULg)
Full Text
See detailLa rispéridone en pédopsychiatrie. Sa place dans l’ensemble de la nosologie, dont les diagnostics non-psychotiques, les liens avec la clinique, des modèles neurophysiologiques d’actions, dont une amélioration de la synthèse des perceptions des émotions ,contexte sociologique et aspects éthiques et anthropologiques.
Scholl, Jean-Marc ULg

in Neurone (2004), 9(4), 1-34

Some children benefit greatly from atypical antipsychotics. In some cases, their use markedly improves these children’s relational and developmental prognosis. The indications for use also include, as is ... [more ▼]

Some children benefit greatly from atypical antipsychotics. In some cases, their use markedly improves these children’s relational and developmental prognosis. The indications for use also include, as is well-known, non-psychotic diagnoses such as: Borderline Personality Disorder, Separation Anxiety Disorder, manic states, and mood swings. This article is the fruit of clinical experience with one atypical antipsychotic, risperdidone, involving more than 230 patients in childhood (80%) or adolescence (20%). After having briefly discussed the atypical antipsychotics in Section I, we will go on in Section II to specify the conditions of effectiveness (in which psychotherapy plays a part), prescription limits, dosage schedules, and side effects of risperidone in relation to the whole gamut of child pyschiatric nosology, drawing both on personal clinical experience and on relevant studies. Section II concludes with an explanatory metaphor that can be helpfully used to communicate with the child and the parents when the drug is first prescribed. Section II also serves to introduce the main hypothesis I want to present in this paper. First, the majority of anamnestic elements we will have discussed in the section are connected with a neurophysiological deficit in the capacity to synthesize perceptions, and particularly with a difficulty in perceiving affects (more below). Second, risperidone corrects, or, in conjunction with other atypical psychotics, helps to correct, the above-mentioned neurobiological deficit. Third, this suggests the need for an empirically-oriented research program aimed at identifying precisely the diverse clinical entities often lumped together under vague terms like “psychosis,” the exact neurobiological deficits underlying them, and the atypical psychotics---as opposed to the classical neuroleptics---that best correct these deficits. This does not call into question the value of psychotherapy, but rather suggests the need for a holistic, multidisciplinary approach that takes account of all relevant factors: neurobiological, psychological, familial, cultural, and so forth. Section III fleshes out this hypothesis by proposing an original neuropsychological model of risperidone’s action that illuminate the clinical experience discussed in Section II. According to this model, risperidone leads to a significant improvement in the synthesis of the perception of emotions and to a better connection between the different neorological zones associated with memory, thus allowing a greater integration of the perceptions. A significant element in Section III will be a critical review of some of the relevant literature. Section IV brings neurological models into dialogue with psychodynamics in light of some concrete clinical cases. What is offered here is just an initial sketch whose value is above all in the proposed approach, which obviously calls for a subsequent interdisciplinary study. Clinical practise, it is suggested, must attend to the world of feelings and subjectivity as a key to understanding the difficulties of the child and the necessity of psychotherapy in conjunction with drug therapy. Section V puts the difficulty of listening to one’s feelings in the context of contemporary Western society, which is not unconnected with the deterioration in mental health. Section V also tackles the ethics of prescribing antipsychotics like risperidone and of the future research with psychotrophic drugs. Finally, Section V also underlines certain aspects of the human being that the action of risperidone brings to light: man as “a being of perception and receptivity”; man’s “faculties”; and the “intuitive intelligence.” The article ends with a brief reflection on “the sense of the mystery of the human being” in order to set the question of determinism into a wider phenomenological context at whose center stands the undivided unity of the human being within interpersonal communion. [less ▲]

Detailed reference viewed: 302 (2 ULg)
Full Text
See detailLes Parents maltraités
Malchair, Alain ULg

in Neurone (2002), 7(3), 83-86

Detailed reference viewed: 54 (3 ULg)
See detailDystonies cervicales
DELVAUX, Valérie ULg; GONCE, Michel ULg

Article for general public (2002)

Detailed reference viewed: 22 (0 ULg)
See detailLa dopamine dans les troubles de l'humeur
PITCHOT, William ULg

in Neurone (2001), 6(8), 255-258

Detailed reference viewed: 11 (1 ULg)
Peer Reviewed
See detailEpilepsies rebelles de l'enfant: définition et modalités de prise en charge hospitalière
Leroy, Patricia; Dubru, Jean-Marie ULg; Misson, Jean-Paul ULg

in Neurone (1997), 2(8), 285-288

Detailed reference viewed: 49 (3 ULg)